Repaglinide
- Product NDC
- 60687-560
- 11-digit product format
- 606870560
- Labeler code
- 60687
- Product ID
- 60687-560_2517f71f-f461-1f56-e063-6394a90a6ef1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA203820
- Marketing category
- ANDA
- Marketing start
- 2020-09-17
- Substance
- REPAGLINIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203820-001 | REPAGLINIDE | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | |
| A203820-002 | REPAGLINIDE | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | |
| A203820-003 | REPAGLINIDE | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203820-001 | AB |
| A203820-002 | AB |
| A203820-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203820-002 | REPAGLINIDE | 1MG | TABLET / ORAL | AB | 2014-01-22 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203820-003 | REPAGLINIDE | 2MG | TABLET / ORAL | AB | RS | 2014-01-22 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203820-001 | REPAGLINIDE | 0.5MG | TABLET / ORAL | AB | 2014-01-22 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203820-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203820-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203820-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203820-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203820-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203820-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203820-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203820-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203820-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203820-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203820-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203820-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203820-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203820-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203820-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203820-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203820-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203820-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203820-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203820-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203820-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203820-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203820-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203820-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203820-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203820-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203820-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203820-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203820-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203820-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203820-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203820-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203820-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203820-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203820-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203820-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203820-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203820-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203820-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203820-001 | AB | 1 | 8072bd15b7f6… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Repaglinide
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| REPAGLINIDE | 1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 668Z8C33LU | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 200256 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| dd1d8337-9903-4b8a-a9ea-569e4d134e74 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ea03026f-270e-3aaa-c14e-f7103b55f75b | Product name | 3 | 20240321 |
| 85cbb42f-1a8d-f945-f85e-188e823b7f5b | Product name | 2 | 20150731 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-560-11 | Repaglinide | 1 in 1 BLISTER PACK | TABLET | 1 | 4 | |
| 60687-560-21 | Repaglinide | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | 6ae28683-28cc-408e-90f9-6a3dddfc668d | 2025-11-04 | Warnings, Adverse reactions | 203820 ANDA203820 |
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | 3b150917-e2fd-4366-af83-ebc1d7297ca9 | 2025-01-16 | Warnings, Adverse reactions | 203820 ANDA203820 |
| Repaglinide | REPAGLINIDE | American Health Packaging | dd1d8337-9903-4b8a-a9ea-569e4d134e74 | 2024-10-22 | Warnings, Adverse reactions | 203820 ANDA203820 60687-560 |
| Repaglinide | REPAGLINIDE | Aurobindo Pharma Limited | 68064989-47ea-4ed5-a20e-43c4ef6ec271 | 2024-05-14 | Warnings, Adverse reactions | 203820 ANDA203820 |
| Repaglinide | REPAGLINIDE | Rising Pharma Holdings, Inc. | d7673e22-0dbb-4395-ad60-943d249203a1 | 2024-05-14 | Warnings, Adverse reactions | 203820 ANDA203820 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 200256 | repaglinide 1 MG Oral Tablet | PSN | dd1d8337-9903-4b8a-a9ea-569e4d134e74 | 4 |
| 200256 | repaglinide 1 MG Oral Tablet | SCD | dd1d8337-9903-4b8a-a9ea-569e4d134e74 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60687-560-11 | 60687056011 | 1 in 1 BLISTER PACK | Historical | |||||
| 60687-560-21 | 60687056021 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-560-21) / 1 TABLET in 1 BLISTER PACK (60687-560-11) | 30 blister pack | 2020-09-17 | 0000-00-00 | No | No | Current |